ICICI Bank Limited
Financial Health

Overall: improving. 3 of 8 areas are trending positively, 5 are stable, and 0 are declining. The strongest signal is asset quality — GNPA has fallen dramatically. The key concern is PAT growth deceleration, which management attributes to branch expansion investments that will pay off in 12-18 months.

Forensic risk is LOW. 3 flags were identified, none critical. INFO: Provision Coverage Ratio declining steadily. WARNING: Corporate rating profile deterioration. INFO: Auditor rotation in FY2025 The 7 clean signals outweigh the flags. Auditors gave an unqualified opinion.

WIDE moat with STRENGTHENING durability. Sources: brand power (4/5), switching costs (5/5), network effects (3/5), cost advantage (4/5), regulatory moat (5/5), intangible assets (4/5). The moat is multi-layered — not dependent on any single advantage.

Credit cycle turn in business banking and unsecured segments — probability: MEDIUM, impact: HIGH. Mitigation: Business banking is 21% of loans growing at 24% — young portfolios haven't been tested through a downturn. Rs 13,100 Cr contingency provisions, 75.8% PCR, and 16.35% CET1 provide buffers. Management's 'risk-calibrated' approach and <50bps credit cost guidance suggest conservative underwriting. | NIM compression beyond management guidance in sustained rate-cut cycle — probability: MEDIUM, impact: MEDIUM. Mitigation: CASA ratio of 41.4% provides natural floor; cost of deposits already falling (4.91% to 4.62%). Term deposit repricing lag is 12-18 months, after which liability-side relief catches up. NIM at 4.32% has been stable for 2 years despite rate cycle shifts. | Regulatory tightening — higher capital requirements, lending restrictions, or fee caps — probability: MEDIUM, impact: MEDIUM. Mitigation: CET1 buffer of 835bps over minimum can absorb significant regulatory capital increases. Diversified income base (fee income 15.3% of total) reduces dependence on any single revenue stream. RBI's track record suggests gradual, well-communicated changes rather than sudden policy shocks.

NIM trajectory — does it hold at 4.30%+ or start compressing below 4.2% as rate cuts deepen?. Cost-to-income — does it improve from 39.7% as new branches contribute, or worsen further toward 40%+?. Business banking asset quality — any uptick in slippages from the 24% growth segment?. Deposit growth vs loan growth — does the LDR (86.6%) stabilize or continue rising toward 90%?. BB and below corporate book — does it remain at 0.5% or expand as rating downgrades occur?

Credit costs spiking above 80bps for 2 consecutive quarters — would signal asset quality cycle has turned. GNPA reversing above 2.0% — would undo the multi-year cleanup and suggest systemic portfolio issues. NIM compressing below 3.8% — would destroy the ROA advantage and compress valuation premium. CET1 falling below 14% without growth to justify it — would signal capital consumption from losses. Management change — Sandeep Bakhshi departure without a credible successor would create significant uncertainty. Large-ticket corporate fraud or NPA (Rs 5,000+ Cr single exposure) — would question underwriting quality. Regulatory action — any RBI directive restricting operations, imposing penalties, or questioning governance